Preclinical evaluation of Vaxfectin(®)-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

Increasing the potency and supply of seasonal and pandemic influenza vaccines remains an important unmet medical need which may be effectively accomplished with adjuvanted egg- or cell culture-derived vaccines. Vaxfectin(®), a cationic lipid-based adjuvant with a favorable safety profile in phase 1...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smith, Larry R., Wodal, Walter, Crowe, Brian A., Kerschbaum, Astrid, Bruehl, Peter, Schwendinger, Michael G., Savidis-Dacho, Helga, Sullivan, Sean M., Shlapobersky, Mark, Hartikka, Jukka, Rolland, Alain, Barrett, P. Noel, Kistner, Otfried
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901827/
https://ncbi.nlm.nih.gov/pubmed/23857272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.24209
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items